Columnist Jolie Lizana attended the Pulmonary Hypertension Association's (PHA) PHPN Symposium, which discussed PH research.
Gossamer Bio has begun the process of acquiring Respira Therapeutics and its lead on-demand PH treatment candidate, RT234.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback